clinical trial · NCT07575269
Evaluation of the FARAFLEX Mapping and Pulsed Field Ablation System in Subjects With Atrial Fibrillation
Paroxysmal Atrial Fibrillation (PAF)Persistent Atrial FibrillationFARAFLEX Mapping and Pulsed Field Ablation (PFA) System
brief summary
The goal of this clinical trial is to learn if the FARAFLEX™ Mapping and pulsed field ablation (PFA) System can safely and effectively treat symptomatic, drug-refractory Paroxysmal atrial fibrillation (PAF) and Persistent atrial fibrillation (PersAF). The main question it aims to answer is: Is the FARAFLEX Mapping and PFA System a safe and effective treatment for patients? Participants will undergo an ablation procedure using the FARAFLEX Mapping and PFA System.
started
Jul 7, 2026
primary completion
Jul 20, 2028
completion
Jan 1, 2030
last updated
Sep 24, 2026
official title
Evaluation of the FARAFLEX Mapping and Pulsed Field Ablation System in Subjects With Atrial Fibrillation - A Global Prospective Single Arm Study
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol